baber/WOPTO huggingface dataset:
Patent CA-2593775-A1 (CA)
Inventor: BENNETT KERRY ROBERT
IPC: E04C1/40
Filed: 2006-01-04
Abstract: A composite masonry building block (1) that has an inner core (20) of lighter density than an outer face and includes upper most protrusions (4, 73) and matching lowermost cavities (5, 76) to have an interlocking arrangement with other like blocks. Also disclosed is an inner lighter density material which includes an expanded plastic such as polystyrene with a cement binder. The upper (2) surface of the block (1) may include a plurality of protrusions and lower (3) may have a plurality of cavities (5). The arrangement of the protrusions (4) in relation to the upper surface (2) and the arrangement of cavities (5) in relation to lower surface (3) are such that the protrusions (4) will locate within and interlock with the consistently aligned and placed cavities of the adjacent block.
Patent CA-2594942-A1 (CA)
Title: Belt buckle
Inventor: ANONYCHUK LAWRENCE
IPC: A44B11/00
Filed: 2007-07-25
Abstract: A method of making a decorative stone belt buckle including the steps of selecting a stone for use in the belt buckle, and selecting a buckle base having a stone attachment surface. Then the stone is cut around a perimeter to form a slug having an outer face and an underside, with the perimeter being sized and shaped to register with the buckle base. Then, a wafer is cut from the stone slug wherein the underside of the wafer matches the attachment surface and the outer face is also a cut face. Then, the outer or presentation surface is polished and the wafer is secured to the buckle base. The wafer may also be a compound stone wafer with inlays or sections of different stone or decorative materials.
Patent CA-2595413-A1 (CA)
Title: Integrated reporting of data
Inventor: GARLAND PETER
IPC: G06F11/00
Filed: 2006-01-10
Abstract: Application-specific terminology for a test data element produced by a test management tool is converted into a standard terminology. A mapping strategy is used to map the application-specific terminology to the standard terminology. A report showing the test data element expressed in the standard terminology is delivered.
Patent CA-2597837-A1 (CA)
Inventor: ETCHES ROBERT J
IPC: C12N15/867
Filed: 2006-02-21
Abstract: Transgenes encoding exogenous antibodies are stably integrated into donor cells and are present in the somatic tissue of chimeric birds. The transgenes encode exogenous antibodies and are preferably expressed in the oviduct for collection in the egg. Tissue specificity is provided by selecting the content of the transgene accordingly. Birds whose genome is comprised of trangene-derived exogenous antibody-encoding DNA express exogenous antibodies having desirable chemical properties with increased therapeutic utility compared to antibodies derived from bacterial expression systems.
Patent CA-2598427-A1 (CA)
Title: Packaging decorated with a 3-d bouquet of miniature mulberry paper flowers
Inventor: HO VIRGINA MARY
IPC: B44C5/06
Filed: 2007-07-31
Abstract: This invention is a design for packaging (boxes or paper bags). The packaging is decorated with a bouquet of miniature mulberry paper flowers on the cover or side of the packaging. The miniature mulberry paper flowers can be roses, calla-lilies, daisies, rosebuds, lotuses, dahlia, poinsettias, gypsos, leaves, sunflowers, chrysanthemums, flat flowers, star flowers, tulips and decorating flowers. These flowers can be of different sizes or colors. The arrangement of the flowers' wires along the main stem's wire of the focal flower chosen allows for a 3-D arrangement. The flowers are arranged in the format of a fresh bouquet of flowers done by a western floral designer. This bouquet of flowers is glued onto the packaging box from the underside of the bouquet.  There is the possibility of uncountable permutations of miniature bouquets of flowers. The flowers are bought ready-made from the internet.
Patent CA-2599846-A1 (CA)
Inventor: FRYDA MATTHIAS
IPC: C02F1/467
Filed: 2006-03-01
Abstract: The invention relates to a system for disinfecting low-conductivity liquids, especially water, comprising an electrochemical cell in which electrodes are disposed such that the liquid flushes or flows around the electrodes and in which oxidizing agents are produced from the liquid by applying a current. A  mixing unit (5) in which the oxidizing agents are thoroughly mixed with the liquid is mounted downstream of the electrochemical cell (2) in the direction of flow.
Patent CA-2599891-A1 (CA)
Title: Method of adapting a dental prosthetic item existing as a 3d data set
Inventor: ORTH ULRICH
IPC: A61C13/00
Filed: 2006-03-01
Abstract: The invention relates to a method for adjusting a digital dental prosthesis (5) that is provided as a 3D data record and has been created based on a 3D  data record of a preparation zone (1) which encompasses the actual preparation point (2) and at least one adjacent tooth (3, 4) thereto. In order to adjust the approximal contact between the dental prosthesis (5) and the adjacent tooth (3), a contact area (8) is defined on the adjacent tooth (3), and the dental prosthesis (5) is automatically adjusted to said contact area.
Patent CA-2602705-A1 (CA)
Title: Polymeric prodrug with a reversible aromatic linker
Inventor: RAU HARALD
IPC: A61K47/48
Filed: 2005-03-22
Abstract: A cascade carrier linked prodrug is described which comprises a biologically active moiety and - a masking group having at least one nucleophile and being distinct from the carrier. In one preferred embodiment of the invention, the prodrug has the structure represented by formula (I).
Patent CA-2603405-A1 (CA)
Inventor: HOESS WERNER
IPC: C08J3/00
Filed: 2006-04-11
Abstract: The invention concerns a method for producing a thermoplastic molding material or element, said material or element containing nanometric inorganic particles. In molten state, the thermoplastic is mixed with the nanometric inorganic particles and with a solubilizing agent in a conveyor screw extruder, the pressures and temperatures being adjusted so that the plastic is in melt form and the solubilizing agent in supercritical state. The invention is characterized in that at the output of the extruder, the mixture passes through a slot with a passage less than 20 µm to penetrate into an expansion zone and the molten material, wherein are incorporated the nanometric inorganic particles, is evacuated, reduced into molding material after cooling or transferred into a molding tool to be molded. The invention also concerns the molding material and the molding elements obtained by this method, as well as the uses thereof.
Patent CA-2604060-A1 (CA)
Title: Protected vehicle or ship
Inventor: MEYER HELMUT
IPC: F41H7/04
Filed: 2006-04-11
Abstract: The invention relates to a vehicle which is equipped with seats and/or devic es and which can be used in areas which are at risk from detonations due to min es or similar. Walls, flooring and roofs are equipped with means which can extract the energy of the pressure wave of a detonation by working on a deformation and the flooring is suspended only by cables, rods or chains by means of connections which can be separated. At least one pressure sensor and/or acceleration sensor, which corresponds to a pressure wave, is provide d, a signal is emitted and then explosive charges are ignited. Said explosive charges (11) are arranged on the connections (8) which can be separated and are disconnected before the pressure wave of a detonation reaches the floor (10).
Patent CA-2605265-A1 (CA)
Title: Acetylene derivatives
Inventor: GLATTHAR RALF
IPC: A61K31/166
Filed: 2006-04-24
Abstract: The invention provides compounds of formula (I) wherein R1 represents hydrogen or alkyl; R2 represents an unsubstituted or substituted heterocycle or R2 represents an unsubstituted or substituted aryl; R3 represents alkyl or halogen; X represents a single bond or an alkandiyl-group, optionally interrupted by one ore more oxygen atoms or carbonyl groups or carbonyloxy groups in free base or acid addition salt form, processes for their preparation and their use as pharmaceuticals.
Patent CA-2608770-A1 (CA)
Title: Improved nanobodies against tumor necrosis factor-alpha
Inventor: BEIRNAERT ELS
IPC: C07K16/18
Filed: 2006-05-17
Abstract: The present invention relates to improved Nanobodies~ against Tumor Necrosis Factor-alpha (TNF-alpha), as well as to polypeptides comprising or essentially consisting of one or more of such Nanobodies. The invention also relates to nucleic acids encoding such Nanobodies and polypeptides; to methods for preparing such Nanobodies and polypeptides; to host cells expressing or capable of expressing such Nanobodies or polypeptides; to compositions comprising such Nanobodies, polypeptides, nucleic acids or host cells; and to uses of such Nanobodies, such polypeptides, such nucleic acids, such host cells or such compositions, in particular for prophylactic, therapeutic or diagnostic purposes, such as the prophylactic, therapeutic or diagnostic purposes.
Patent CA-2609555-A1 (CA)
Title: Polymer compositions and adhesives, coatings and sealants made therefrom
Inventor: MISHRA STEVE S
IPC: C08K5/54
Filed: 2006-05-24
Abstract: Polymer compositions for preparing sealants, adhesives and coatings are provide The polymer compositions comprise from 1 to 99% by weight of an organic polym comprising functional silane groups, from 1 to 45% by weight (based on total polymer) of least one reactive or non-reactive organopolysiloxane polymer; from 0 to 98 % by weig (based on total polymer) of an organic polymer that lacks functional silane groups.
Patent CA-2609718-A1 (CA)
Title: Method and apparatus for determining a normal combustion characteristic for an internal combustion engine from an accelerometer signal
Inventor: HUANG JIM
IPC: G01M15/04
Filed: 2007-11-27
Abstract: The method comprises operating a calibration engine, and collecting combustion characteristic data and reference accelerometer signals, which are correlated with each other and stored in a calibration table. The calibration table can be used by an engine to determine a real-time normal combustion characteristic when the engine is operating by collecting a real-time accelerometer sensor signal and cross correlating with the correlated data stored in the calibration table. Accordingly, the apparatus comprises a calibration engine comprising a calibration sensor, a reference accelerometer sensor and a data storage device for storing the collected calibration data that is correlated with the collected reference accelerometer signals, and an engine equipped with an accelerometer sensor, a calibration table and an electronic engine controller programmed to receive real-time accelerometer signals and cross correlate them with reference accelerometer signals to determine a real-time normal combustion characteristic.
Patent CA-2612383-A1 (CA)
Inventor: BLAKERS ANDREW WILLIAM
IPC: H01L31/02
Filed: 2006-06-16
Abstract: A solar cell interconnection process for forming a solar cell sub-module for a photovoltaic device, the process including the steps of mounting a plurality of elongate solar cells (101) on a crossbeam (102) on patches of solderable material (201) which is used to maintain solder in position, the elongate solar cells being in a substantially longitudinally parallel and generally co-planar configuration: and establishing one or more conductive pathways (204) extending between adjacent cells to electrically interconnect the elongate solar cells via the contacts (202, 203): wherein the one or more conductive pathways are established by wave soldering.
Patent CA-2614453-A1 (CA)
Title: Four a chambres avec des joints de dilatation ameliores et briques destinees a sa realisation
Inventor: BIGOT JEAN
IPC: F27B13/06
Filed: 2006-07-10
Abstract: L'invention concerne les fours à feu tournant dont au moins une des cloisons intérieures est formée d'une pluralité de briques en matériau réfractaire incluant au moins une première (15a) et une deuxième (15b) briques placées au- dessus ou au- dessous d'une troisième brique (15c) et séparées l'une de l'autre d'un espace (13, 14) de largeur J, dans lesquels la première brique (15a) comporte au moins un évidement (158d, 158'd) sur sa face d'assemblage en regard de la troisième brique (15c), la troisième brique (15c) comporte au moins un bossage (155d, 155'd) sur sa face d'assemblage en regard de la première brique (15a), le bossage étant engagé dans l'évidement, la dimension E dudit évidement (158d) dans le sens long de la cloison est plus grande que la dimension B dudit premier bossage (155d) dans le même sens, et ledit évidement (158d) est espacé d'une distance déterminée Se de la face d'extrémité (152) adjacente audit espace (13, 14). L'invention permet à certaines briques de glisser les unes sur les autres, tout en maintenant la cohésion et la solidité de la cloison, lors des mouvements provoqués par la dilatation et la contraction des briques.
Patent CA-2615088-A1 (CA)
Inventor: VIOLA FRANK J
IPC: A61B17/068
Filed: 2007-12-17
Abstract: An articulating surgical instrument is provided including a handle, an articulating portion extending distally of the handle and an end effector positioned on a distal end of the articulating portion. A flexible drive band is provided for movement through the articulating portion and end effector. The flexible drive band includes a first portion having a first height and the second portion having a second height greater than the first height. The difference in heights being sufficient to eject staples from a body portion of the end effector into an anvil member of the end effector. An actuation mechanism is provided for drawing the flexible drive band through the articulating surgical instrument.
Patent CA-2616565-A1 (CA)
Title: Utilisation d'un polypeptique pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
Inventor: PERRON HERVE
IPC: C07K7/08
Filed: 2000-07-17
Abstract: Utilisation d'au moins un polypeptide comprenant au moins un fragment d'une protéine pour obtenir une composition diagnostique, pronostique, prophylactique ou thérapeutique destinée à détecter, prévenir ou traiter un état pathologique associé à une maladie dégénérative et/ou neurologique et/ou auto-immune, ladite protéine étant choisie parmi les protéines dont la séquence peptidique à l'état natif correspond à SEQ ID N~ 1, SEQ ID N~ 2, SEQ  ID N~ 3, SEQ ID N~ 4, SEQ ID N~ 5, SEQ ID N~ 6, SEQ ID N~ 7, SEQ ID N~ 8, SEQ ID N~ 10, SEQ ID N~ 11, SEQ ID N~ 12, SEQ ID N~ 13, SEQ ID N~ 14, SEQ ID N~ 15, SEQ ID  N~ 16, SEQ ID N~ 17, SEQ ID N~ 18, SEQ ID N~ 19, SEQ ID N~ 20, SEQ ID N~ 21, SEQ  ID  N~ 22, SEQ ID N~ 23, SEQ ID N~ 24, SEQ ID N~ 25, SEQ ID N~ 26, SEQ ID N~ 27, SEQ  ID N~ 28 et SEQ ID N~ 29, et les séquences peptidiques qui présentent au moins 70 %  d'identité, de préférence au moins 80 % d'identité et avantageusement au moins 98 %  d'identité avec l'une quelconque des séquences peptidiques SEQ ID N~ 1 à SEQ  ID N~ 8 et SEQ ID N~ 10 à SEQ ID N~ 29, et les séquences peptidiques ou les fragments desdites séquences appartenant à une même famille de protéines choisies parmi le perlecan, le précurseur de la protéine plasmatique de liaison au rétinol, du précurseur de l'activateur du ganglioside GM2, de la calgranuline B et de la saposine B.
Patent CA-2616592-A1 (CA)
Title: Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy
Inventor: TOMA EMIL
IPC: A61K31/7068
Filed: 2006-07-13
Abstract: Boosted cytidine analogue reverse transcriptase inhibitor antiretroviral compound is a new therapeutic anti HIV option, in combination with another drug such as a NRTI or a protease inhibitor. It's heightened and sustained antiretroviral potency is due to the increased intracellular level of 3TC  triphosphate, the active form of 3TC. This effect is obtained by combining 3TC, in usual doses, with a reduced dose of ddC, in the same pharmaceutical formulation. The product could be administered twice or even once daily, which is convenient, and does not increase the pill burden for the patient. The reduced ddC dosage prevents the occurrence of ddC related side effects. Other cytidine derivatives (racemic or negative enantiomers) could have the same effects as ddC and could probably be combined with 3TC, and have the same effect. On the other hand, low dose ddC may also increase the intracellular levels of other cytidine derivatives as it does for 3TC. Boosted cytidine analogue reverse transcriptase inhibitor antiretroviral compound could also be formulated in combination with another drug such as another NRTI (e.g.  abacavir) or any protease inhibitor in the same capsule or tablet. This approach offers a dual anti-HIV therapy that is as efficacious as the routine triple therapy. In this way the HIV treatment cost could be significantly reduced which is imperative for resource-poor settings. This new formulation is convenient and well tolerated with no additional toxicity than that of the combining drug (NRTI or protease inhibitor) and 3TC. Moreover, this will enable a larger number of patients to benefit from the already known 3TC  effects. It will also increase the 3TC effects in those organs or HIV  sanctuaries with usually reduced 3TC concentrations or activity. It could be indicated in both the initial as well as in salvage HIV therapy. It could also be used for therapy optimization or simplification. Moreover, in combination with another NRTI such as abacavir, or even alone, it could be beneficial for reducing the HIV harm in resource-poor settings.
Patent CA-2619811-A1 (CA)
Inventor: ADHIKARI AKSHAY
IPC: H04W12/06
Filed: 2008-01-30
Abstract: A method is disclosed that enables the transmission of a digital message along with a corresponding information signal, such as audio or video. The supplemental information contained in digital messages can be used for a variety of purposes, such as enabling or enhancing packet authentication. In particular, a telecommunications device that is processing an information signal from its user, such as a speech signal, encrypts the information signal by performing a bitwise exclusive-or of an encryption key stream with the information signal stream. The device, such as a telecommunications endpoint, then intersperses the bits of the digital message throughout the encrypted signal in place of those bits overwritten, in a process referred to as "watermarking." The endpoint then transmits the interspersed digital message bits as part of a composite signal that also comprises the encrypted information bits. No additional bits are appended to the packet to be transmitted, thereby addressing compatibility issues.
Patent CA-2620488-A1 (CA)
Inventor: TAKESHIMA ICHIRO
IPC: E04B1/18
Filed: 2006-03-24
Abstract: [PROBLEMS] To provide a building structure with a tube frame formed of a novel basic structure capable of securing excellent structural stability and quake-resistance in buildings, particularly, high rises and skyscrapers, and realizing the larger degree of freedom of design than that of a conventional building structure with a tube frame. [MEANS FOR SOLVING THE PROBLEMS] This building structure includes the outer peripheral tube frame having a main frame formed by rigidly joining hexagonal structural units to each other in a honeycomb shape. The hexagonal structural unit includes columns and a part of a beam or a slab. Specifically, in the hexagonal structural unit, two sides, each of which is formed by connecting, to each other, two tilted columns tilted reverse to each other in the vertical direction, are disposed symmetrical bilaterally, and either of a part of the beam or a part of the slab is disposed on the upper side and the lower side of the unit along the horizontal direction.
Patent CA-2624496-A1 (CA)
Title: Plants with an increased production of hyaluronan ii
Inventor: FROHBERG CLAUS
IPC: C12N9/10
Filed: 2006-10-05
Abstract: The invention concerns plant cells and plants, which synthesize an increased amount of hyaluronan, and to methods for producing these plants as well as to methods for producing hyaluronan with the aid of these plant cells or plant.  According to the invention, plant cells or genetically modified plants have the activity of a hyaluronan synthesis and an increased activity of a UDP  glucose dehydrogenase (UDP-GIc-DH) in comparison to wild type plant cells or wild type plants. The invention also relates to the use of plants with increased hyaluronan synthesis for producing hyaluronan and food- and feedstuffs containing hyaluronan.
Patent CA-2626947-A1 (CA)
Title: Fiber optic splice storage apparatus and methods for using the same
Inventor: ALLEN BARRY W
IPC: G02B6/44
Filed: 2006-10-23
Abstract: A fiber optic splice storage apparatus (100) includes a central segment (112) defining a splice chamber configured to receive a plurality of fiber optic splices, a first slack fiber storage segment (120) pivotally connected to a first end of the central segment (112) and having an open position extending from the first end (118) away from the central segment (112) and a closed position extending over the central segment (112) , and a second slack fiber storage segment (130) pivotally connected to a second end (122) of the central segment (112) , opposite the first end (119) , the second slack fiber storage segment (130) having an open position extending from the second end (122) away from the central segment (112) and a closed position extending over the central segment (112) . A first plurality of slack fiber guide members (105) on the first slack fiber storage segment (120) are configured to receive and retain a loop of optical fibers and a second plurality of slack fiber guide members (110) on the second slack fiber storage segment (130) are configured to receive and retain a loop of optical fibers.
Patent CA-2629031-A1 (CA)
Inventor: LANGER GERNOT
IPC: C07C405/00
Filed: 2006-11-20
Abstract: The present invention relates to 9-chloroprostaglandin derivatives of the general formula (I) which may be advantageous for the treatment of fertility problems.
Patent CA-2629548-A1 (CA)
Inventor: MORO MICHELE
IPC: C11D7/54
Filed: 2008-05-02
Abstract: A composition of Sodium Metabisulphite and water can be used for the removal of red wine stains from fabrics, up to and including clothing, carpets, cottons, linens, etc. When this liquid form is poured or sprayed onto a fabric containing a stain formed from the tannin particles in red wine, the liquid composition can quickly break down the tannins in the wine and allow the red color to dissipate and dry without residue. If any residue were to remain, it would be left in a salt-like crystal form and can be brushed off, vacuumed or washed out of the material.
Patent CA-2629973-A1 (CA)
Title: Hydraulic cylinder
Inventor: JOEBSTL HORST
IPC: F15B15/14
Filed: 2006-10-26
Abstract: In a hydraulic cylinder (11) for a multiple-part mast superstructure comprising at least two mast arms which are connected in an articulated manner and of which one can be pivoted with respect to the other mast arm by the hydraulic cylinder, it is proposed that the base region (18) of the cylinder container (12) is of curved configuration, which cylinder container (12) is closed in the base region (18) on one side in order to accommodate a piston. In this way, the force flux is improved in the walls of the hydraulic cylinder, with the result that manufacturing which uses less material and is correspondingly less expensive is possible, with a simultaneously reduced overall weight. The hydraulic cylinder according to the invention is suitable, in particular, for use with concrete pumps, cranes, lifting platforms and the like or general apparatuses having mast superstructures, in which hydraulic cylinders are used for pivoting.